These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 25860064)
1. Targeting chromatin remodeling to prevent cardiovascular disease in diabetes. Costantino S; Paneni F; Cosentino F Curr Pharm Biotechnol; 2015; 16(6):531-43. PubMed ID: 25860064 [TBL] [Abstract][Full Text] [Related]
2. A Recent Update on the Epigenetic Repertoire and Chromatin Modifying Therapy in Diabetes Mellitus: A Comprehensive Review. Wang X; Zhao D; Beeraka NM; Tatineni S; Sri CD; Nishanth VV; Uthiah CA; Leihang Z; Sugur K; Liu J; Nikolenko VN; Fan R Curr Med Chem; 2023; 30(18):2020-2038. PubMed ID: 35927905 [TBL] [Abstract][Full Text] [Related]
3. Epigenetic modifications in metabolic memory: What are the memories, and can we erase them? Chen Z; Natarajan R Am J Physiol Cell Physiol; 2022 Aug; 323(2):C570-C582. PubMed ID: 35785987 [TBL] [Abstract][Full Text] [Related]
4. Epigenetic Changes in Diabetes and Cardiovascular Risk. Keating ST; Plutzky J; El-Osta A Circ Res; 2016 May; 118(11):1706-22. PubMed ID: 27230637 [TBL] [Abstract][Full Text] [Related]
5. Glucose-independent persistence of PAI-1 gene expression and H3K4 tri-methylation in type 1 diabetic mouse endothelium: implication in metabolic memory. Takizawa F; Mizutani S; Ogawa Y; Sawada N Biochem Biophys Res Commun; 2013 Mar; 433(1):66-72. PubMed ID: 23454124 [TBL] [Abstract][Full Text] [Related]
6. Epigenetic signatures and vascular risk in type 2 diabetes: a clinical perspective. Paneni F; Costantino S; Volpe M; Lüscher TF; Cosentino F Atherosclerosis; 2013 Oct; 230(2):191-7. PubMed ID: 24075743 [TBL] [Abstract][Full Text] [Related]
8. Approaches to prevention of cardiovascular complications and events in diabetes mellitus. Coccheri S Drugs; 2007; 67(7):997-1026. PubMed ID: 17488145 [TBL] [Abstract][Full Text] [Related]
10. Differential epigenetic factors in the prediction of cardiovascular risk in diabetic patients. Napoli C; Benincasa G; Schiano C; Salvatore M Eur Heart J Cardiovasc Pharmacother; 2020 Jul; 6(4):239-247. PubMed ID: 31665258 [TBL] [Abstract][Full Text] [Related]
11. Remodeling is at the heart of chromatin: the heartaches of chromatin. El-Osta A Epigenetics; 2011 Jul; 6(7):884-7. PubMed ID: 21646860 [TBL] [Abstract][Full Text] [Related]
12. The epigenetic landscape in the cardiovascular complications of diabetes. Costantino S; Ambrosini S; Paneni F J Endocrinol Invest; 2019 May; 42(5):505-511. PubMed ID: 30291588 [TBL] [Abstract][Full Text] [Related]
19. Small molecule modulators of histone acetylation and methylation: a disease perspective. Selvi BR; Mohankrishna DV; Ostwal YB; Kundu TK Biochim Biophys Acta; 2010; 1799(10-12):810-28. PubMed ID: 20888936 [TBL] [Abstract][Full Text] [Related]
20. Epigenetic therapy in cancer: molecular background and clinical development of histone deacetylase and DNA methyltransferase inhibitors. Schneider-Stock R; Ocker M IDrugs; 2007 Aug; 10(8):557-61. PubMed ID: 17665331 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]